What is MENTANINE®?Mentanine® is a natural pure plant-based pharmaceutical-grade cannabidiol (CBD) isolate plus natural omega-3 ingredients IP formula. Pre-clinical trial results have demonstrated that it effectively crosses the blood-brain barrier “BBB” and supports the health of the brain function responsible for neurological conditions such as anxiety, depression, PTSD, and addiction.
Anxiety and depression have been an issue for those you love and possibly yourself for generations, and yet, even with all the science we currently have no one has really created a formula that can actually help the brain on a deep level.
We combine just the right amount of CBD with Omega 3 Essential Fatty Aids to create the most unique formula supporting mental health function through healthy endocannabinoid receptors. If you or someone you know suffers from depression, anxiety, or any other mental illness, we invite you to try Mentanine®. The fact that the formula is mostly Omega-3s and only small amount of CBD, the risk of any side effect is negligible.
Acts on the central nervous system (the brain) and the endocannabinoid system
Mentanine® may be formulated in a powder or liquid form. Administered orally as either a capsule or sublingually (under the tongue) as a tincture with the water-soluble solution. One Mentanine® powder-filled capsule contains 21.5 mg of water-soluble CBD + IP formula. The synergistic effect resulting from CBD with omega-3 active ingredients is significantly more effective than pure water-soluble CBD.
To ensure safety and effectiveness we advise first-time users to consult their physicians, especially patients taking antidepressants. Although our table may not list all antidepressants that can be affected by CBD, it demonstrates a warning to not mix anti-depressing drugs with CBD.
The advantage of Mentanine® is its effectiveness and efficacy, – only a small oral dose of 30mg to 60mg of CBD daily is recommended by our scientists, as compared to a wide range of oral doses from 100mg/day to 800mg/day.
Mental Health conditions
Mentanine® is highly bioavailable and is a fast-acting formula that has the ability to act on inflammation within the Central Nervous System (CNS), the brain. This type of inflammation contributes to neurological conditions such as Anxiety, Depression, Schizophrenia, PTSD, or Addiction.
Scientifically Developed Formulation
- Molecules synergistically bind to PPAR receptors that facilitate Mentanine® to cross the blood-brain barrier (BBB) for ultimate and consistent efficacy.
- Pharmaceutical-grade – highly concentrated cannabidiol (CBD) isolate.
- Essential Fatty Acids (EFAs) with a specific concentration of active Omega-3 ingredients
- Efficient food-grade supply chain process – from cultivation and processing to distribution.
- GMP manufacturing facility, with ISO certified processing.
Pre-Clinical Trials ResultsPre-clinical trial results – published in peer-reviewed European Journal of Neuroscience. Oct. 2020.
- Multiple times the efficacy as compared to CBD alone.
- Reduced Anxiety, Depression, PTSD, and Addictive effects.
- Showed a significant reduction of inflammation, which could be beneficial for reduction of anxiety, depression, PTSD, addiction and in same cases in pain management.
The Scientific Difference
CBD vs Mentanine®
- Does not effectively cross the blood-brain barrier “BBB”.
- Thus, CBD alone is marginally effective for treating mental ailments.
- Required high dose can cause negative side effects (especially toxicity of the liver).
- Molecules bond and synergistically attach to PPAR receptors allowing Mentanine® to enter the brain, with amplified effects and efficacy.
- Supports neurological conditions.
- Requires minimum doses of CBD, yielding increased efficacy since Mentanine® effectively crosses the “BBB”.
*Study conducted by Dr. W McIntyre Burnham, Ontario Brain Institute, emeritus professor of the University of Toronto’s Temerty Faculty of Medicine